Creating Silicon Valley in Europe: Public Policy Towards New Technology Industries

Creating Silicon Valley in Europe: Public Policy Towards New Technology Industries

Volumn , Issue , 2007, Pages 1-224

  Casper, Steven ^a  

^a KECK GRADUATE INSTITUTE   (United States)

Author keywords

Biotechnology; Europe; Germany; Innovation; Software; Technology Clusters; Technology Policy; Uk; Varieties of Capitalism

Indexed keywords

EID: 84920989849     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1093/acprof:oso/9780199269525.001.0001     Document Type: Book

References (204)

1. Abramson, N., Encarnacao, J., Reid, P., and Schmoch, U. (eds.) (1997). Technology Transfer Systems in the United States and Germany. Washington, DC: National Academy Press.
2. Adelberger, K. (2000). 'Semi-Sovereign Leadership? The State's Role in German Biotechnology and Venture Capital Growth', German Politics, 9: 103-22.
3. AlexanderX (2004). Bioscience Directory: 2004 San Diego Edition. San Diego, CA: AlexanderX Publishing.
4. Almeida, P. and Kogut, B. (1999). 'Localization of Knowledge and the Mobility of Engineers in Regional Networks', Management Science, 45(7): 905-17.
5. Amable, B. (2004). The Diversity of Modern Capitalism. Oxford: Oxford University Press.
6. Andersen, A. (1998). Technology Transfer in the UK Life Sciences. UK: Arthur Andersen/Garrets/Dundas & Wilson.
7. Arthur, B. (1994). Increasing Returns and Complexity in the Economy. Ann Arbor: University of Michigan Press.
8. Asakawa, K. and Lehrer, M. (2004). 'Pushing Scientists into the Marketplace: German and Japanese Efforts to Promote Science Entrepreneurship', California Management Journal, 46(3): 55-76.
9. Audretsch, D. (1995). 'The Innovation, Unemployment, and Competitiveness Challenge in Germany', Wissenschaftszentrum Berlin (WZB) Discussion Paper FS IV 95-6.
10. Audretsch, D. (2000). 'Germany, along with Europe, Is Embracing the New Economy', European Affairs, 1 (Summer): 3.
11. Bahrami, H. and Evans, S. (1995). 'Flexible Re-Cycling and High-Technology Entrepreneurship', California Management Review, 37(3, Spring): 62-88.
12. BioRegio Germany (1998). 'Federal Minister Presents "Miracle in Germany" at Bio 1998', Press Release, BioRegio Germany, June 16.
13. Blackburn, L. (2006). 'Thumbs Up for U.K. Biobank', ScienceNow, Aug. 22.
14. BMBF (2001a). Bericht zur technologischen Leistungsfaehigkeit Deutschlands 2001. Bonn: BMBF.
15. Blackburn, L. (2001b). 'Funding of Growth: Initiatives in Biotechnology', Bonn: BMBF. Publik.
16. (p.193) Blackburn, L. (2004). 'BMBF Funding in the Sphere of Biotechnology', BMBF Press Release, Feb. 2.
17. Blackburn, L. (2006a). Bericht zur technologischen Leistungsfaehigkeit Deutschlands 2006. Bonn: BMBF.
18. Blackburn, L. (2006b). 'Biotechnologie-Chancen nutzen und gestalten', Program announement for the 'BioChance' program. URL: http://www.bmbf.de/foerderungen/6899.php (accessed Oct. 26, 2006)
19. Boehm, T. and Schuehsler, H. (2003). 'Where Do Biotechnology Venture Capitalists Go from Here?', Munich, Germany: Techno Venture Management.
20. Breschi, S. and Malerba, F. (1997). 'Sectoral Innovation Systems: Technological Regimes, Schumpeterian Dynamics, and Spatial Boundaries', in C. Edquist (ed.), Systems of Innovation: Technologies, Institutions and Organizations. London: Pinter, pp. 130-55.
21. Büchtemann, C. and Vogler-Ludwig, K. (1997). Das deutsche Ausbildungsmodell unter Anpassungszwang: Thesen zur Humankapitalbildung in Deutschland. Munich, Germany: IFO Institute.
22. Buck, T., Shahrim, A., and Winter, S. (2004). 'Executive Stock Options in Germany: The Diffusion or Translation of US-Style Corporate Governance', Journal of Management and Governance, 8: 173-86.
23. Casper, S. (2000). 'Institutional Adaptiveness, Technology Policy, and the Diffusion of New Business Models: The Case of German Biotechnology', Organization Studies, 21: 887-914.
24. Casper, S. (2001). 'The Legal Framework for Corporate Governance: The Influence of Contract Law on Company Strategies in Germany and the United States', in Peter Hall and David Soskice (eds.), Varieties of Capitalism. Oxford: Oxford University Press, pp. 387-416.
25. Casper, S. (2003a). 'Career Structures and Competitive Dynamics of Research Organizations in the Life Sciences: When and Why Do Labs Develop Ties with Firms', Paper Presented at the Society for the Advancement of Socio-Economics Annual Meeting, London.
26. Casper, S. (2003b). 'The German Internet Economy and the "Silicon Valley Model": Convergence, Divergence, or Something Else?', in Bruce Kogut (ed.), The Global Internet Economy. Boston, MA: MIT Press, pp. 223-62.
27. Casper, S. (2007). 'How Do Technology Clusters Emerge and Become Sustainable? Social Network Formation and Inter-Firm Mobility within the San Diego Biotechnology Cluster', Research Policy 36(4).
28. Casper, S. and Glimstedt, H. (2001). 'Economic Organization, Innovation Systems, and the Internet', Oxford Review of Economic Policy, 17: 265-81.
29. Casper, S. and Karamanos, A. (2003). 'Commercializing Science in Europe: The Cambridge Biotechnology Cluster', European Planning Studies, 11 (October): 805-22.
30. Casper, S. and Kettler, H. (2001). 'National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The German and UK Biotechnology Sectors', Industry and Innovation, 8.
31. (p.194) Casper, S. and Matraves, K. (2004). 'Institutional Frameworks and Innovation in the German and UK Pharmaceutical Industry', Research Policy, 32(2003): 1865-79.
32. Casper, S. and Murray, F. (2003). 'Examining the Marketplace for Ideas: How Local Are European Biotechnology Clusters', in Maureen Mcklevey and Jens Hageman (eds.), Industrial Dynamics in European Biotechnology. London: Edward Elgar.
33. Casper, S. and Murray, F. (2004). 'Careers and Clusters: Analyzing Career Network Dynamics of Biotechnology Clusters', Journal of Engineering and Technology Management, 22: 51-74.
34. Casper, S. and Soskice, D. (2004). "Sectoral Systems of Innovation and Varieties of Capitalism: Explaining the Developmant of High-Technology Entrepreneurship in Europe." In F. Malerba, ed. Sectoral Systems of Innovation in Europe. Cambridge: Cambridge University Press.
35. Casper, S. and Vitols, S. (1997). 'The German Model in the 1990s: Problems and Prospects', Industry and Innovation, 4: 3-12.
36. Casper, S. and Whitley, R. (2004). 'Managing Competences in Entrepreneurial Technology Firms: A Comparative Institutional Analysis of Germany, Sweden and the UK', Research Policy, 33(1): 89-106.
37. Casper, S., Lehrer, M., and Soskice, D. (1999). 'Can High-Technology Industries Prosper in Germany: Institutional Frameworks and the Evolution of the German Software and Biotechnology Industries', Industry and Innovation, 6: 6-23.
38. Castells (1996). The Rise of the Network Society. Oxford: Blackwell.
39. Cellzome (2003). "Cellzome Hits Target on Series C Financing." Press Release, Cellzome AG, Heidelberg, Germany.
40. Cellzome (2005). "Cellzome Announces Expansion of Pathway Collaboration." Press Release, Cellzone AG, Heidelberg, Germany.
41. Charkham, J. (1995). Keeping Good Company: A Study of Corporate Governance in Five Countries. Oxford: Oxford University Press.
42. Cioffi, J. (2002). "Restructuring 'Germany, Inc.': The Corporate Governance Debate and the Politics of Company Law Reforms," Law & Policy, vol. 24(4): 355-402.
43. Cooke, P. (1999). 'Biotechnology Clusters in the UK: Lessons from Localisation in the Commercialization of Science', Centre for Advanced Studies, Cardiff University, Cardiff.
44. Crabtree, P. (2003). 'A Magical Place', San Diego Union Tribune, Sept. 14.
45. Crouch, C. and Streeck, W. (1997). Modern Capitalism or Modern Capitalisms? London: Francis Pinter.
46. Culpepper, P. (2003). Creating Cooperation: How States Develop Human Capital in Europe. New York: Cornell University Press.
47. Cusamano, M. and Selby, R. (1995). Microsoft Secrets. New York: Free Press.
48. Cusamano, M. and Yoffie, D. (1998). Competing on Internet Time: Lessons from Netscape and Its Battle with Microsoft. New York: Free Press.
49. (p.195) Davidson, S. (2000). 'British Biotech Redefines Itself', Nature Biotechnology, 187: 821-2.
50. Deeg, R. (1999). Finance Capitalism Unveiled: Banks and the German Political Economy. Ann Arbor, MI: University of Michigan Press.
51. Deutsche Bundesbank (1997). Monthly Report, April.
52. DeVol, P. W., Ki, J., Bedroussian, A., and Koepp, R. (2005). America's Biotech and Life Science Clusters: San Diego's Position and Economic Contributions. Los Angeles, CA: Milken Institute.
53. Dickman, S. (1996). 'Germany Joins the Biotech Race', Science, 274: 1454.
54. DiMaggio, P. J. (1988). 'Interest and Agency in Institutional Theory', Institutional Patterns and Organisations. Cambridge, MA: Ballinger.
55. DiMaggio, P. and Powell, W. (1983). 'The Iron Cage Revisited: Institutional Isomorphism and Collective Rationality in Organizational Fields', American Sociological Review, 48: 147-60.
56. DiMasi, J., Hansen, R., and Grabowski, H. (2003). 'The Price of Innovation: New Estimates of Drug Development Costs', Journal of Health Economics, 22(2): 151-85.
57. Dodd, A. (1999). The Essential Guide to Telecommunications. New York: Prentice Hall.
58. Easterbrook, F. and Fischel, D. (1991). The Economic Structure of Corporate Law. Cambridge, MA: Harvard University Press.
59. The Economist (1997). 'Glaxo: Coping with Unwelcome News', April 26, pp. 87-8.
60. Easterbrook, F. and Fischel, D. (1999). 'Business: And Then Came the Europeans', March 13, 1999 Perrow, 1985.
61. Easterbrook, F. and Fischel, D. (2005). 'Baying for Blood or Doling Out Cash', Dec. 20.
62. Edwards, J. and Fischer, K. (1994). Banks, Finance and Investment in Germany. Cambridge, MA: Cambridge University Press.
63. Ernst & Young (1998a). 'Aufbruchstimmung 1998: First German Biotechnology Survey', Munich, Germany: Ernst & Young.
64. Edwards, J. and Fischer, K. (1998b). European Life Sciences 98-Continental Shift. London: Ernst & Young International.
65. Edwards, J. and Fischer, K. (2000a). European Life Sciences 2000. London: Ernst & Young International.
66. Edwards, J. and Fischer, K. (2000b). 'Gruenderzeit: Deutscher Biotechnologie Report 2000', Mannheim, Germany: Ernst & Young.
67. Edwards, J. and Fischer, K. (2001). European Life Sciences 2001. London: Ernst & Young International.
68. Edwards, J. and Fischer, K. (2002). 'Neue Chancen: Deutscher Biotechnologie Report 2002', Mannheim, Germany: Ernst & Young.
69. Edwards, J. and Fischer, K. (2004). Ernst and Young's 2004 Global Biotechnology Report. London: Ernst & Young International.
70. Edwards, J. and Fischer, K. (2005a). Kraefte der Evolution: Deutscher Biotechnologie Report 2005. Mannheim, Germany: Ernst & Young.
71. Edwards, J. and Fischer, K. (2005b). Ernst and Young's 2005 Global Biotechnology Report. London: Ernst & Young International.
72. (p.196) Ferguson, C. (1999). High Stakes, No Prisoners: A Winner's Tale of Greed and Glory in the Internet Wars. New York: Crown Business.
73. Fikes, Bradley (1999). 'Why San Diego Has Biotech', San Diego Metropolitan. http://www.sandiegometro.com/1999/apr/biotech.html (accessed June 29, 2006)
74. Finegold, D. and Soskice, D. (1988). 'The Failure of Training in Britain: Analysis and Prescription', Oxford Review of Economic Policy, 4: 21-53.
75. Fleming, L., King, C., and Juda, A. (2006). 'Small Worlds and Regional Innovation', Working Paper, Harvard Business School, March 21.
76. Fligstein, N. (1997). 'Social Skill and Institutional Theory', American Behavioral Scientist, 40: 397-405.
77. Florida, R. and Kenney, M. (1988). 'Venture Capital-Financial Innovation and Technological Change in the USA', Research Policy, 17: 119-37.
78. Franzese, R. (2001). 'Institutional and Sectoral Interactions in Monetary Policy and Wage/Price-Bargaining', in P. Hall and D. Soskice (eds.), Varieties of Capitalism. Oxford: Oxford University Press, pp. 104-44.
79. Gans, J. and Stern, S. (2003). 'The Product Market and the Market for 'Ideas': Commercialization Strategies for Technology Entrepreneur', Research Policy, 32(2): 333-50.
80. Garnsey, E. and Cannon-Brookes, A. (1983). 'The "Cambridge Phenomenon" Revisited: Aggregate Change among Cambridge High-Technology Companies since 1985', Entrepreneurship and Regional Development, 5(2): 179-207.
81. Gilder, G. (2000). Telecosm. New York: Free Press.
82. Gilson, R. J. (1999). 'The Legal Infrastructure of High Technology Industrial Districts: Silicon Valley, Route 128, and Covenants Not to Compete', New York University Law Review, 74(3).
83. Glimstedt, H. (2001). 'Competitive Dynamics of Technological Standardization: The Case of Third Generation Cellular Communications,' Industry and Innovation, 8: 49-78.
84. Glimstedt, H. and Zander, U. (2003). 'Sweden's Wireless Wonders: Defining the Swedish Internet Economy', in B. Kogut (ed.), The Global Internet Economy. Cambridge, MA: MIT Press.
85. Gourevitch, P. and Shinn, J. (2005). Political Power and Corporate Control: The New Global Politics of Corporate Governance. Princeton, NJ: Princeton University Press.
86. Granovetter, M. (1973). 'The Strength of Weak Ties', American Journal of Sociology, 78(6), May: 1360-80.
87. Greene, T. (2000). 'Newbridge Sells Out after Years of Missed Chances', Network Word, 28(Feb.): 16.
88. Hall, P. and Gingerich, D. (2004). 'Varieties of Capitalism and Institutional Complementarities in the Macroeconomy: An Empirical Analysis', Max Planck-Institute for the Studies of Societies, Cologne, Discussion Paper 04/05.
89. Hall, P. and Gingerich, D. and Soskice, D. (2001). 'Introduction', in Peter Hall and David Soskiceed (eds.), Varieties of Capitalism. Oxford: Oxford University Press, pp. 1-70.
90. (p.197) Hancké, B. (2002). Large Firms and Institutional Change: Industrial Renewal and Economic Restructuring in France. Oxford: Oxford University Press.
91. Hauser, H. (2000). 'Entrepreneurship in Europe', Business Strategy Review, 11: 1-9.
92. Heller, M. and Eisenberg, R. (1998). 'Can Patents Deter Innovation? The Anticommons in Biomedical Research', Science, 280: 698.
93. Henderson, R., Orsenigo, L., and Pisano, G. (1999). 'The Pharmaceutical Industry and the Revolution in Molecular Biology: Interactions among Scientific, Institutional and Organizational Change', in D. Mowery and R. Nelson (eds.), Sources of Industrial Leadership-Studies of Seven Industries. Cambridge, MA: Cambridge University Press.
94. Higgins, M. (2005). Career Imprints: Creating Leaders Across an Industry. New York: John Wiley & Sons.
95. Hollingsworth, R. (1997). 'Continuities and Changes in Social Systems of Production: The Cases of Germany, Japan, and the United States', in R. Hollingsworth and R. Boyer (eds.), Contemporary Capitalism. Cambridge, MA: Cambridge University Press, pp. 265-310.
96. Hyde, A. (1998). 'Employment Law after the Death of Employment', University of Pennsyvania Journal of Labor Law, 1: 105-20.
97. Jackson, T. (1997). Inside Intel: Andrew Grove and the Rise of the World's Most Powerful Chip Company. New York: Dutton.
98. Kalb, K. (2006). 'Mergers: Miracle or Madness', Wood Mackenzie, corporate presentation, March. Url: http://units.sla.org/division/dpht/meetings/spring2006/2006-kalb.pdf (accessed Nov. 16, 2006)
99. Katzeinstein, P. (1978). 'Conclusion: Domestic Structures and Strategies of Foreign Economic Policy', in P. Katzeinstein (ed.), Between Power and Plenty. Madison, WI: University of Wisconsin Press.
100. Katzeinstein, P. (1987). Policy and Politics in West Germany: Towards the Growth of a Semi-Sovereign State. Philadelphia, PA: Temple University Press.
101. Katzeinstein, P. (1989). 'Stability and Change in the Emerging Third Republic', in P. Katzenstein (ed.), Industry and Politics in West Germany. Ithaca, NY: Cornell University Press.
102. Keller, B. (1991). Einführung in die Arbeitspolitik. München, Germany: Oldenbourg.
103. Kenney, M. (1986). Biotechnology: The University-Industrial Complex. New Haven, CT: Yale University Press.
104. Kenney, M. (ed.) (2000). Understanding Silicon Valley: The Anatomy of an Entrepreneurial Region. Palo Alto, CA: Stanford University Press.
105. Kettler, H. and Casper, S. (2001). The Road to Sustainability in the UK and German Biotechnology Industries. London: Office of Health Economics.
106. Kidder, T. (1981). The Soul of a New Machine. Boston, MA: Back Bay Books.
107. Kitschelt, H. (1991). 'Industrial Governance, Innovation Strategies, and the Case of Japan: Sectoral Governance or Cross-National Comparative Analysis?', International Organization, 45: 453-93.
108. (p.198) Knorr Cetina, K. (1999). Epistemic Cultures. How the Sciences Make Knowledge. Cambridge, MA: Harvard University Press.
109. Kreps, D. (1990). "Corporate Culture and Economic Theory." in J. Alt and K. Shepslle, ed. Perspectives on Positive Political Economy. Cambridge: Cambridge University Press, 1990.
110. Lampel, S. (2005). 'Biotechnology and Its Funding in Germany', Presentation given at the NBCC Partnering Event, Bonn, Oct. 25.
111. Lange, K. (2005). Deutsche Biotech-Unternehmen und ihre Innovationsfähigkeit im internationalen Vergleich: eine institutionentheoretische Analyse, Dissertation, University of Gronningen.
112. Lee, C. and M. Walshok. (2002). "Making Connections: The Evolution of Links Between UCSD Researchers and San Diego's Biotech Industry." Unpublished report, UCSD Connect.
113. Lehrer, M. (1997). 'German Industrial Strategy in Turbulence: Corporate Governance and Managerial Hierarchies in Lufthansa', Industry and Innovation, 4: 115-34.
114. Lehrer, M. (2000). 'Has Germany Finally Solved Its High-Tech Problem? The Recent Boom in German Technolology-Based Entrepreneurism', California Management Review, 42: 89-107.
115. Lehrer, M. (2006). 'Two Types of Organizational Modularity: SAP, ERP, Product Architecture and the German Tipping Point in the Make/Buy Decision for IT Services', in M. Miozzo and D. Grimshaw (ed.), Knowledge Intensive Business Services: Organizational Forms and National Institutions. London: Edward Elgar.
116. Lerner, J. and Gompers, P. (2001). The Money of Invention: How Venture Capital Creates New Wealth. Cambridge, MA: Harvard Business School Press.
117. Malerba, F. and Orsenigo, L. (1993). 'Technological Regimes and Firm Behavior', Industrial and Corporate Change, 2: 45-71.
118. Mares, I. (2003). The Politics of Social Risk: Business and Welfare State Development. Cambridge, MA: Cambridge University Press.
119. Martin, R. (1989). 'The Growth and Geographical Anatomy of Venture Capitalism in the United Kingdom', Regional Studies, 23: 389-403.
120. Martin, R., Sunley, P., and Turner, D. (2002). 'Taking Risks in Regions: The Geographical Anatomy of Europe's Emerging Venture Capital Market', Journal of Economic Geography, 21: 121-50.
121. Meek, V. (2005). 'Rising from the Ashes?', European Venture Capital Journal, Dec./Jan. 2005: 6-14.
122. Meissner, H. and Naschold, F. (1999). 'Internationalisierung durch strategische Allianzbildung zsischen Siemsna dn Newbridge: Aus dem monopolitschen Heimatmarkt auf den kompetiven nordamerikanischen "Lead-Market" in einem neuen Technologiefeld', in Frieder Naschold, Christoph Doerrenbaecher, Heinz-Rudolf Meissner, and Leo Renneke (eds.), Kooperieren ueber Grenzen: Evolutionsprozesse globaler Produktentwicklungsverbuende in der InfoCom-Industrie, manuscript: WZB, pp. 82-137.
123. (p.199) Micromet (2004). 'Micromet to Realign Operations', Press Release, Jan. 28.
124. Milgrom, P. and Roberts, J. (1993). Economics, Organization, and Management. Eaglewood Cliffs, NJ: Prentice-Hall.
125. Milgrom, P. and Roberts, J. (1995). 'Complementarities: Industrial Strategy, Structure, and Change in Manufacturing', Journal of Accounting and Economics, 19: 179-208.
126. Miller, G. (1992). Managerial Dilemmas. Cambridge, MA: Cambridge University Press.
127. Mowery, D. (1999). 'The Computer Software Industry', in D. Mowery and R. Nelson (eds.), Sources of Industrial Leadership. Cambridge, MA: Cambridge University Press.
128. Mowery, D. and Nelson R. (1999). Sources of Industrial Leadership. Cambridge, MA: Cambridge University Press.
129. Mowery, D., Sampat, B., and Ziedonis, A. (2004). Ivory Tower and Industrial Innovation: University-Industry Technology Transfer before and after the Bayh-Dole Act in the United States. Palo Alto, CA: Stanford University Press.
130. Müller, C. and Rump, A. (2002). 'Time for Consolidation in Germany', Nature Biotechnology, 20: 441-4.
131. Murray, F. (2004). 'The Role of Inventors in Knowledge Transfer: Sharing in the Laboratory Life', Research Policy, 33(4): 643-59.
132. National Science Foundation (2006). Science and Engineering Indicators. Washington DC: National Science Foundation.
133. Nightingale, P. (2000). 'Economies of Scale in Experimentation: Knowledge and Technology in Pharmaceutical R&D', Industrial and Corporate Change, 9: 315-59.
134. NIH (2006). 'Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs', NIH Webiste: http://grants.nih.gov/grants/funding/sbirsttr_programs.htm (accessed June 29, 2006).
135. North, D. and Weingast, B. (1995). 'Constitutions and Commitment: The Evolution of Institutions Governing Public Choice in Seventeenth Century England', Journal of Economic History, 49: 803-32.
136. Paulson, E. (2001). Inside Cisco: The Real Story of Sustained M&A Growth. New York: John Wiley & Sons.
137. Pennan, H. (1996). 'R&D Strategy in a Techno-Economic Network: Alzheimer's Disease Therapeutic Strategies', Research Policy, 25: 337-58.
138. Perrow, C. (1984). Normal Accidents: Living with High Risk Technologies. New York: Basic Books.
139. PhRMA (1996). 'Industry profile', Washington, DC: PhRMA.
140. Pontusson, J. and Swenson, P. (1996). 'Labour Markets, Production Strategies, and Wage Bargaining Institutions: The Swedish Employer Offensive in Comparative Perspective', Comparative Political Studies, 29: 223-50.
141. Pope, J. (2006). 'Donors Give All-Time Record to Colleges', Boston Globe, Feb. 16.
142. Porter, M. (1985) Competitive Advantage. New York: Free Press.
143. Powell, W. (1996). 'Inter-Organizational Collaboration in the Biotechnology Industry', Journal of Institutional and Theoretical Economics, 152(1): 197-215.
144. (p.200) Powell, W., White, D., Koput, K., and Owen-Smith, J. (2005). 'Network Dynamics and Field Evolution: The Growth of Inter-Organizational Collaboration in the Life Sciences', American Journal of Sociology, 110: 1132-205.
145. Hollingsworth, R. and Boyer, R. (eds.) (1997). Contemporary Capitalism. Cambridge, MA: Cambridge University Press.
146. Rabinow, P. (1996). Making PCR: A Study of Biotechnology. Chicago, IL: Chicago University Press.
147. Robbins-Roth (2000). From Alchemy to IPO: The Business of Biotech. New York: Persus Books.
148. Roe, M. (1994). Strong Managers, Weak Owners: The Political Roots of American Corporate Finance. Princeton, NJ: Princeton University Press.
149. Sabel, C. (1996). 'Constitutional Orders: Trust Building and Response to Change', in Roger Hollingsworth and Robert Boyer (eds.), Contemporary Capitalism: The Embeddedness of Institutions. Cambridge, MA: Cambridge University Press.
150. Sako, M. (2003). 'Between Bit Valley and Silicon Valley: Hybrid Forms of Business Governance in the Japanese Internet Economy', in Kogut, B. (ed.), The Global Internet Economy. Boston, MA: MIT Press.
151. San Diego SourceBook (2006). 'On-Line Directory of San Diego Venture Capital Firms', URL: http://sourcebook.sddt.com/2006/(accessed June 29, 2006)
152. Saunders, J. (1998). 'Newbridge Stock Tumbles after Ominous Prediction', Computing Canada, Feb. 23: 34.
153. Saxenian, A. (1994). Regional Advantage. Cambridge, MA: Harvard University Press.
154. Saxenian, A. (1996). 'Beyond Boundaries: Open Labor Markets and Learning in Silicon Valley', in M. Arthur and D. Rousseau (eds.), Boundaryless Careers: Work, Mobilty, and Learning in the New Organizational Era. New York: Oxford University Press.
155. Schmitter, P. and Streeck, W. (1985). Private Interest Government. London: Sage.
156. Schumpeter, J. (1950). Capitalism, Socialism, and Democracy, 3rd edn. New York: Harper and Row.
157. Senker, J. (1996). 'National Systems of Innovation, Organizational Learning and Industrial Biotechnology', Technovation, 16: 219-29.
158. S. G. Cowen, (1998). 'Biotechnology in Europe-A Road Map for Investors with Lessons from America', Perspectives, Septm.
159. Shapiro, C. and Varian, H. (1999). Information Rules. Cambridge, MA: HBS Press.
160. Sheridan, C. (2003). 'Germany Biotech Gets Second Chance', Nature Biotechnology, 21: 1414.
161. Shonfeld, A. (1965). Modern Capitalism. Oxford: Oxford University Press.
162. Simard, C. (2004). 'From Weapons to Cell Phones: Knowledge Networks in San Diego's Wireless Valley', Dissertation, Stanford University.
163. Sorge, A. and Streeck, W. (1988). 'Industrial Relations and Technical Change: The Case for an Extended Perspective', in R. Hyman and W. Streeck (eds.), New Technology and Industrial Relations. Oxford: Basil Blackwell, pp. 19-47.
164. (p.201) Soskice, D. (1997). 'German Technology Policy, Innovation, and National Institutional Frameworks', Industry and Innovation, 4: 75-96.
165. Statistische Bundesamt (2005). 'No Slump, but No Breakthrough of Biotechnology Either', Press Release, Oct. 12.
166. Steinmo, S., Thelen, K., and Longstretch, F. (eds.) (1992). Structuring Politics: Historical Instituitonalism in Comparative Analysis. Cambridge, UK: Cambridge University Press.
167. Sternberg, R. and Tamasy, C. (1999). 'Munich as Germany's No. 1 High Technology Region: Empirical Evidence, Theoretical Explanations and the Role of Small Firm/Large Firm relationships', Regional Studies, 33: 367-77.
168. Streeck, W. (1984). Industrial Relations in West Germany: A Case Study of the Car Industry. New York: St. Martin's Press.
169. Streeck, W. (1992). 'On the Institutional Preconditions of Diversified Quality Production', in W. Streeck (ed.), Social Institutions and Economic Performance. London and Newberry Park, CA: Sage.
170. Streeck, W. (1996). 'German Capitalism: Does It Exist? Can It Survive?', in C. Crouch and W. Streeck (eds.), Modern Capitalism or Modern Capitalisms? London: Francis Pinter.
171. Streeck, W. (1997). 'Beneficial Constraints: On the Economic Limits of Rational Voluntarism', in R. Hollingsworth and R. Boyer (eds.), Contemporary Capitalism. Cambridge, MA: Cambridge University Press.
172. Sulston, J. and Ferry, G. (2002). The Common Thread. London: Bantam Press.
173. Tbg (2001). Sectoral Distribution of Public Venture Capital. http://www.tbgbonn.de/info/index.html (accessed June 2001).
174. Teece, D. (1986). 'Profiting from Technological Innovation: Implications for Integration, Collaboration, Licensing, and Public Policy', Research Policy, 15: 285-305.
175. Thelen, K. (1991). Union of Parts. Ithaca, NY: Cornell University Press.
176. Thelen, K. (2004). How Institutions Evolve: The Political Economy of Skills in Germany, Britain, Japan and the United States. Cambridge, MA: Cambridge University Press.
177. Trumbull, G. (2004). Silicon and the State: French Innovation Policy in the Internet Age. Washington, DC: Brookings Institution Press.
178. Turner, L. (1991). Democracy at Work: Changing World Markets and the Future of Labor Unions. Ithaca, NY: Cornell University Press.
179. UCSD Connect (2004). 'Universities and Regional Development: The San Diego Experience', Presentation access on-line at: http://www.hhh.umn.edu/img/assets/11469/lee_ppt_presentation.pdf (accessed June 29, 2006)
180. UK Department of Health (2002). 'Britain Must Be at the Leading Edge of Genetics-Milburn', Press Release 2002/0025, Jan. 16.
181. UK Department of Trade and Industry (1999). 'Genome Valley Report-The Economic Potential and Strategic Importance of Biotechnology in the UK', London: Department of Trade and Industry.
182. (p.202) UK Department of Trade and Industry (2006). 'Comparative Statistics for the UK, European, and US Biotechnology Sectors, Analysis Years 2003 and 2004', London: DTI.
183. Uzzi, B. and Spiro, J. (2005). 'Collaboration and Creativity: The Small World Problem', American Journal of Sociology, 11: 447-504.
184. Vitols, S. (2001). 'Varieties of Corporate Governance: Comparing Germany and the UK', in P. Hall and D. Soskice (eds.), Varieties of Capitalism: The Institutional Foundations of Comparative Advantage. Oxford: Oxford University Press, pp. 337-60.
185. Vitols, S. and Engelhardt, L. (2005). 'National Institutions and High Tech Industries: A Varieties of Capitalism Perspective on the Failure of Germany's 'Neuer Markt', WZB Discussion Paper SP II 2005-03, Berlin: WZB February 2005.
186. Vitols, S., Casper, S., Soskice, D. and Wolcock, S. (1997). Corporate Governance in Large British and German Companies. London: Anglo-German Foundation.
187. Wassermann, S. and Faust, K. (1994). Social Network Analysis. Cambridge, MA: Cambridge University Press.
188. Watts, G. (2006). 'Will the UK Biobank Pay Off?', British Medical Journal, 332: 1052.
189. Weintraub, A. (2006). 'Bucking the Odds at Amylin', Business Week, Jan. 9.
190. Wellcome Trust (1998). Mapping the Landscape: National Biomedical Research Outputs, 1988-95. Policy Report Nr. 9. London: The Wellcome Trust.
191. Werth, B. (1994). The Billion-Dollar Molecule. New York: Touchstone, Simon & Schuster.
192. West, J. (2001). 'The Mystery of Innovation: Aligning the Triangle of Technology, Institutions and Organisation', Australian Journal of Management, 26 Special Issue, August.
193. Whitley, R. (1999). Divergent Capitalisms: The Social Structuring and Change of Business Systems. Oxford: Oxford University Press.
194. Whitley, R. (2003). 'Competition and Pluralism in the Public Sciences: The Impact of Institutional Frameworks on the Organization of Academic Science', Research Policy, 32: 1015-29.
195. Whitley, R. (2006). 'Project-Based Firms: New Organizational Form or Variations on a theme?', Industrial and Corporate Change, 15: 77-99.
196. Williamson, O. (1975). Markets or Hierarchies: Analysis and Antitrust Implications. New York: Free Press.
197. Winter, S. (1987). 'Knowledge and Competence as Strategic Assets', in D. J. Teece (ed.), The Competitive Challenge: Strategies for Industrial Innovation and Renewal. Cambridge, MA: Ballinger.
198. Wood, S. (2001). 'Business, Government, and Patterns of Labor Market Policy in Britain and the Federal Republic of Germany', in Hall and Soskice (ed.), Varieties of Capitalism. Oxford: Oxford University Press, pp. 247-74.
199. Woodward, J. (1965). Industrial Organization: Theory and Practice. Oxford: Oxford University Press.
200. Yamamura, K. and Streeck, W. (eds.) (2003). The End of Diversity: Prospects for German and Japanese Capitalism. Cornell, NY: Cornell University Press.
201. (p.203) Yankee Group (1999). Telecommunications Ranking Charts. New York: Yankee Group.
202. Zider, B. (1998). 'How Venture Capital Works', Harvard Business Review, 76(6): 131-9.
203. Zucker, L., Darby M., and Brewer, M. (1998). 'Intellectual Human Capital and the Birth of U.S. Biotechnology Enterprises', American Economic Review, 88(1): 290-306.
204. Zysman, J. (1983). Governments, Markets, and Growth: Finance and the Politics of Industrial Change. Cornell, NY: Cornell University Press.